[go: up one dir, main page]

ES463022A1 - Procedimiento para la obtencion de fenoxi-amino-propanoles. - Google Patents

Procedimiento para la obtencion de fenoxi-amino-propanoles.

Info

Publication number
ES463022A1
ES463022A1 ES463022A ES463022A ES463022A1 ES 463022 A1 ES463022 A1 ES 463022A1 ES 463022 A ES463022 A ES 463022A ES 463022 A ES463022 A ES 463022A ES 463022 A1 ES463022 A1 ES 463022A1
Authority
ES
Spain
Prior art keywords
atoms
case
propanols
amino
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES463022A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES463022A1 publication Critical patent/ES463022A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para la obtención de fenoxi-amino-propanoles de fórmula general I **(Fórmula)** Donde R1 significa alquenilo, alquinilo, alcoxialquilo o alqueniloxi-alquilo, en cada caso con 2 ¿ 6 átomos de carbono, o cicloalquilo con 3 ¿ 8 átomos de carbono y R2 significa alquilo o hidroxialquilo, en cada caso con 1 ¿ 6 átomos de carbono, cicloalquilo con 3 ¿ 8 átomos de carbono, aralquilo insustituido o aralquilo sustituido en el resto arilo una hasta tres veces por alquilo, alcoxi, OH, F y/o C1 o simplemente por metilendioxi, con en cada caso 7 ¿ 15 átomos de carbono, así como sus sales de adición de ácido fisiológicamente compatibles.
ES463022A 1976-10-09 1977-10-07 Procedimiento para la obtencion de fenoxi-amino-propanoles. Expired ES463022A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2645710A DE2645710C2 (de) 1976-10-09 1976-10-09 Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
ES463022A1 true ES463022A1 (es) 1978-12-16

Family

ID=5990109

Family Applications (1)

Application Number Title Priority Date Filing Date
ES463022A Expired ES463022A1 (es) 1976-10-09 1977-10-07 Procedimiento para la obtencion de fenoxi-amino-propanoles.

Country Status (21)

Country Link
US (2) US4171370A (es)
JP (1) JPS5346930A (es)
AT (1) AT357143B (es)
AU (1) AU520307B2 (es)
BE (1) BE859425A (es)
CA (1) CA1110253A (es)
CH (1) CH630337A5 (es)
DE (1) DE2645710C2 (es)
ES (1) ES463022A1 (es)
FR (1) FR2367053A1 (es)
GB (1) GB1532380A (es)
HK (1) HK39483A (es)
HU (1) HU177868B (es)
IL (1) IL53063A (es)
IT (1) IT1091303B (es)
NL (2) NL185665C (es)
PT (1) PT67083B (es)
SE (1) SE441827B (es)
SG (1) SG7192G (es)
YU (1) YU40820B (es)
ZA (1) ZA776018B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative
JPS56144222A (en) * 1980-04-10 1981-11-10 Teijin Ltd False twisted crimped yarn
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
US4472427A (en) * 1980-12-23 1984-09-18 Merck & Co., Inc. (Aralkylamino-2-OR-propoxy)heterocyclic compounds
DE3125636A1 (de) * 1981-06-30 1983-01-13 Merck Patent Gmbh, 6100 Darmstadt 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
FR2512443A1 (fr) * 1981-09-10 1983-03-11 Synthelabo Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
JPS5891855A (ja) * 1981-11-27 1983-05-31 株式会社クラレ 寝装用ポリエステル繊維ステープル綿およびその製造法
DE3151201A1 (de) * 1981-12-23 1983-07-28 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
WO1988007036A1 (en) * 1987-03-16 1988-09-22 University Of Florida LABILE KETONE DERIVATIVES OF 3-SUBSTITUTED-1-ALKYLAMINO-2-PROPANOLS AND THEIR USE AS beta-ADRENERGIC BLOCKERS
EP0300290B1 (de) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phenoxypropanolamine
ES2011584A6 (es) * 1989-05-26 1990-01-16 Esteve Quimica Sa Procedimiento industrial para la obtencion de una ariloxipropanolamina.
DE3920369A1 (de) * 1989-06-22 1991-01-10 Merck Patent Gmbh Migraenemittel
US5217994A (en) * 1991-08-09 1993-06-08 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ATE215369T1 (de) * 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CN100338026C (zh) * 2002-07-12 2007-09-19 北京四环医药科技股份有限公司 制备比索洛尔及其盐的改进方法
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
EA201100293A1 (ru) 2003-01-14 2011-08-30 Джилид Сайэнс, Инк. Способ (варианты) и фармацевтическая композиция (варианты) для лечения или профилактики симптомов вич-инфекции
CN1812983A (zh) * 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CL2007002044A1 (es) * 2006-07-14 2008-06-13 Ranbaxy Lab Ltd Polimorfo cristalino de la sal hemicalcica del acido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3,5-dihidroxiheptanoico; composicion farmaceutica; y uso para el tratamiento de la diabetes, enf
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US10849863B2 (en) 2011-04-28 2020-12-01 University Of Louisville Research Foundation, Inc. Compounds for treating cancer, for administering, and for pharmaceutical compositions
CA2909442A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
HUE069590T2 (hu) 2019-01-18 2025-03-28 Astrazeneca Ab PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások
GB202102575D0 (en) 2021-02-23 2021-04-07 Teva Pharmaceutical Industries Ltd Fixed-dose pharmaceutical compositions
GB2627294A (en) 2023-02-20 2024-08-21 Novumgen Ltd A fast-disintegrating tablet of bisoprolol or pharmaceutically acceptable salts thereof and its process of preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465640A (de) * 1964-09-10 1968-11-30 Ciba Geigy Verfahren zur Herstellung neuer Amine
US3483221A (en) * 1964-09-10 1969-12-09 Ciba Geigy Corp 1 - (isopropylamino)-2-hydroxy-3-(alkenyloxyphenoxy) - propanes and the salts thereof
ES361530A1 (es) * 1967-12-18 1970-11-01 Boehringer Sohn Ingelheim Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi 3-sec - alcohilamino propanos racemicos u opticamente activos.
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE2065985A1 (de) * 1969-05-16 1977-08-04 Yoshitomi Pharmaceutical Phenoxyaminopropanolverbindungen
SE372762B (es) * 1969-05-21 1975-01-13 Haessle Ab
GB1276968A (en) * 1970-01-15 1972-06-07 Lepetit Spa Improvements in or relating to phenylacetamides and the preparation thereof
SE354851B (es) * 1970-02-18 1973-03-26 Haessle Ab
US3929856A (en) * 1971-12-14 1975-12-30 Parke Davis & Co 1-(3,4-Dimethoxyphenethylamino)-3-(phenoxy)-2-propanols
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
SG7192G (en) 1992-07-24
BE859425A (nl) 1978-04-06
FR2367053B1 (es) 1981-11-27
SE7711278L (sv) 1978-04-10
IL53063A0 (en) 1977-12-30
NL185665C (nl) 1990-06-18
NL185665B (nl) 1990-01-16
HK39483A (en) 1983-10-13
AU520307B2 (en) 1982-01-28
NL930020I2 (nl) 1993-09-16
JPS5346930A (en) 1978-04-27
AU2946477A (en) 1979-04-12
CA1110253A (en) 1981-10-06
PT67083A (de) 1977-10-01
US4258062A (en) 1981-03-24
DE2645710C2 (de) 1985-06-27
NL7711042A (nl) 1978-04-11
PT67083B (de) 1979-02-22
YU40820B (en) 1986-06-30
JPS6210220B2 (es) 1987-03-05
NL930020I1 (nl) 1993-05-03
DE2645710A1 (de) 1978-04-13
ZA776018B (en) 1978-05-30
US4171370A (en) 1979-10-16
CH630337A5 (de) 1982-06-15
SE441827B (sv) 1985-11-11
AT357143B (de) 1980-06-25
IL53063A (en) 1981-06-29
YU236877A (en) 1983-01-21
ATA717377A (de) 1979-11-15
GB1532380A (en) 1978-11-15
IT1091303B (it) 1985-07-06
FR2367053A1 (fr) 1978-05-05
HU177868B (en) 1982-01-28

Similar Documents

Publication Publication Date Title
ES463022A1 (es) Procedimiento para la obtencion de fenoxi-amino-propanoles.
IE41627L (en) Triazolyl-alkanones/alkanols
IE40913B1 (en) Substitited amides their use as fungicides
EP0055105A3 (en) Triazolinones, and their production and use
IE782472L (en) Stilbene derivatives.
IE822410L (en) Substituted azetidinols
IE43450L (en) 6, 7-benzomorphans
EP0213727A3 (en) Measuring circuit
ES427728A1 (es) Procedimiento para la obtencion de imidazolil-o, n-acetales.
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
IE40570L (en) Benzylamine derivatives
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
IL62905A0 (en) Aminopropiophenone derivatives,their preparation and their use as fungicides
IE811312L (en) Benzopyran derivatives
ES8100278A1 (es) Un procedimiento para la preparacion de derivados de 5-triazina
ES433680A1 (es) Procedimiento para la preparacion de derivados de arilpipe-razinicos de la adenina.
ATE15370T1 (de) 3-piperidinyl-indole derivate, ihre salze, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende arzneimittel.
IL62906A (en) Phenylpropylamine derivatives,their preparation and their use as fungicides
IE801068L (en) Substituted acetophenones.
ATE64392T1 (de) Thiazolidin-4-one-derivate un deren saeureadditionssalze.
ES339432A1 (es) Un procedimiento para la obtencion de nuevas tetrahidro- quinazolinas sustituidas por halogenos.
IE34993L (en) Indenophthalazines
ES8404338A1 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
GR3001943T3 (en) Fungicidal cyclohexylamines
ES468586A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.